LCN2 and breast cancer: Here, effective delivery of Lcn2 siRNA to breast cancer cells MCF-7 and TNBC MDA-MB-231 was achieved by encapsulating Lcn2 siRNA in cationic liposomes and decorating them on the surface with Octreotide (OCT) peptide ligand.